Avicanna Inc. AVCNF AVCN (FSE:0NN) has closed a non-brokered private placement offering of 1.8 million units of the company at a price of $0.35 per unit for aggregate gross proceeds of approximately $626,762. Each unit is comprised of one common share in the capital of the company and one-half of one common share purchase warrant of the company and, each warrant shall entitle the holder thereof to acquire one common share in the capital of the company at an exercise price of $0.40 per share, subject to adjustment in certain events, until November 10, 2025.
The company has paid an aggregate total of approximately $13,649 in cash finders' fees and issued an aggregate total of 39,000 finder's warrants in connection with the offering to certain finders in connection with subscriptions for units made by purchasers introduced to the company by such finders. Each finder warrant entitles the holder thereof to acquire one common share in the capital of the company at an exercise price of $0.40 per share, subject to adjustment in certain events, until November 10, 2025.
The company intends to use the proceeds from the offering for general working capital purposes, general and administrative expenses, expenditures related to production and manufacturing, and research and clinical development.
The unit shares and warrants, and any securities issuable upon conversion or exercise thereof, are subject to a four-month hold period under applicable securities laws in Canada. The offering is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including the approval of the Toronto Stock Exchange.
Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.
Photo by Giorgio Trovato on Unsplash
Related News
Avicanna Announces Extension Of Term Loan
Avicanna Formalizes Its Patent Application For Cannabinoid-Based Epilepsy Medication
Avicanna Launches A Medical Cannabis Education Portal For Health Care Professionals
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.